News
SNN
33.04
+0.61%
0.20
Zimmer Biomet: Execution Remains The Sticking Point
Seeking Alpha · 5d ago
Alphatec is the top performing healthcare equipment stock YTD
Seeking Alpha · 6d ago
Weekly Report: what happened at SNN last week (1215-1219)?
Weekly Report · 6d ago
Canaccord Genuity Reaffirms Their Hold Rating on Smith & Nephew Snats (SNN)
TipRanks · 12/17 12:08
Smith & Nephew price target lowered to 1,482 GBp from 1,563 GBp at Morgan Stanley
TipRanks · 12/15 16:55
Weekly Report: what happened at SNN last week (1208-1212)?
Weekly Report · 12/15 10:34
Smith & Nephew downgraded to Sector Perform from Outperform at RBC Capital
TipRanks · 12/15 09:45
RBC Capital Sticks to Their Hold Rating for Smith & Nephew (SN)
TipRanks · 12/15 07:05
Smith & Nephew (SN) Receives a Buy from Citi
TipRanks · 12/15 06:35
*Smith & Nephew Target Cut to GBP13.50 From GBP17 by RBC
Dow Jones · 12/15 05:54
*Smith & Nephew Cut to Sector Perform From Outperform by RBC
Dow Jones · 12/15 05:54
Smith & Nephew Snats: Hold Rating Amid Strategic Ambitions and Execution Risks
TipRanks · 12/12 12:45
OssDsign AB Appoints Mark Waugh as CEO
Reuters · 12/10 07:00
Kepler Capital Sticks to Their Buy Rating for Smith & Nephew (SN)
TipRanks · 12/10 01:35
Goldman Sachs Sticks to Its Buy Rating for Smith & Nephew (SN)
TipRanks · 12/09 14:17
Smith & Nephew: Poised for Growth with Strategic Investments and Strong Product Pipeline
TipRanks · 12/09 11:35
EUROPE RESEARCH ROUNDUP- BMW, EQT, Nestle
Reuters · 12/09 07:42
Barclays Sticks to Their Hold Rating for Smith & Nephew (SN)
TipRanks · 12/09 07:25
Smith+Nephew Unveils RISE Strategy and 2028 Financial Targets
TipRanks · 12/08 12:17
More
Webull provides a variety of real-time SNN stock news. You can receive the latest news about Smith & Nephew through multiple platforms. This information may help you make smarter investment decisions.
About SNN
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.